CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 4 enrolled
Drug / intervention
Methylphenidate ERdrug
Likely dose
Methylphenidate ER 18mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01100268
NCT01100268Phase 2Completed
CompareCT.gov

Enhancing Attention in Adults With Compulsive Hoarding: A Pilot Study

New York State Psychiatric Institute·interventional·Posted Apr 8, 2010·Updated Sep 18, 2014

In Brief

A Phase 2 clinical trial evaluating Methylphenidate ER for Hoarding Disorder. Completed, enrolled 4 participants across 2 sites.

Detailed Summary

Available data suggest that compulsive hoarders have cognitive deficits, particularly with sustaining attention that might contribute their hoarding symptoms.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHoarding Disorder
CountriesUnited States
CollaboratorsHartford Hospital

Timeline

Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedApr 8, 2010
Enrollment StartApr 1, 2010
Primary CompletionApr 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 16.2 years ago

Interventions

Methylphenidate ERdrug

Subjects will start at 18mg/day; the dose will be increased in increments of 18mg per week to reach 72mg/day.